In recent years, the use of boosted protease inhibitors monotherapy has become increasingly important, especially considering the advantages in terms of costs, tolerability, and simplification. Despite that, knowledge about the efficacy and safety of this approach in HIV-1-infected adolescents who have acquired HIV-1 infection through perinatal transmission is still limited. We report here our experience with two adolescents who have been successfully treated with lopinavir/ritonavir monotherapy. ©2012 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.

Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection.

SCHENONE, EVA;DI BIAGIO, ANTONIO;PARISINI, ANDREA;BRUZZONE, BIANCA;STICCHI, LAURA;CALZI, ANNA;NICCO, ELENA;SECONDO, GIOVANNI;VISCOLI, CLAUDIO
2012

Abstract

In recent years, the use of boosted protease inhibitors monotherapy has become increasingly important, especially considering the advantages in terms of costs, tolerability, and simplification. Despite that, knowledge about the efficacy and safety of this approach in HIV-1-infected adolescents who have acquired HIV-1 infection through perinatal transmission is still limited. We report here our experience with two adolescents who have been successfully treated with lopinavir/ritonavir monotherapy. ©2012 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11567/378411
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact